+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Vitiligo Drug"

Vitiligo Treatment Global Market Report 2024 - Product Thumbnail Image

Vitiligo Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Vitiligo Therapeutics: Global Strategic Business Report - Product Thumbnail Image

Vitiligo Therapeutics: Global Strategic Business Report

  • Report
  • February 2024
  • 192 Pages
  • Global
From
From
From
From
Vitiligo - Epidemiology Forecast to 2032 - Product Thumbnail Image

Vitiligo - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Vitiligo - Pipeline Insight, 2021 - Product Thumbnail Image

Vitiligo - Pipeline Insight, 2021

  • Clinical Trials
  • May 2021
  • 70 Pages
  • Global
From
Global Vitiligo Therapeutics Market 2022-2026 - Product Thumbnail Image

Global Vitiligo Therapeutics Market 2022-2026

  • Report
  • June 2022
  • 120 Pages
  • Global
From
US Vitiligo Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Vitiligo Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
From
Loading Indicator

The Vitiligo Drug market is a subset of the Dermatological Drugs market, which includes drugs used to treat skin conditions. Vitiligo is a skin condition characterized by the loss of skin color in patches, and is caused by the destruction of melanocytes, the cells responsible for skin pigmentation. Vitiligo drugs are used to treat the condition by restoring the skin's pigmentation. The Vitiligo Drug market is composed of a variety of drugs, including topical corticosteroids, topical calcineurin inhibitors, phototherapy, and systemic medications. Topical corticosteroids are used to reduce inflammation and stimulate melanocyte production, while topical calcineurin inhibitors are used to reduce inflammation and prevent the destruction of melanocytes. Phototherapy is used to stimulate melanocyte production, while systemic medications are used to reduce inflammation and stimulate melanocyte production. The Vitiligo Drug market is highly competitive, with a number of companies offering products to treat the condition. Some of the companies in the market include Novartis, Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more